Recent data from the Hong Kong Stock Exchange indicates that on February 16, JPMorgan acquired an additional 347,233 shares of SINOPHARM (01099) at an average price of HK$21.4135 per share. The total transaction value amounted to approximately HK$7.4355 million.
Following this purchase, JPMorgan's total shareholding in SINOPHARM has reached around 67.1203 million shares, representing a 5% stake in the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.